Destroy Pancreatic Cancer dedicates $1 million for unique TGen-designed clinical trial
Share

PHOENIX, Ariz. and Atlanta, Ga. — March 12, 2018 — Destroy Pancreatic Cancer, an Atlanta-based non-profit dedicated to finding better treatments for the most deadly of all cancers, is donating $1 million for a unique pancreatic cancer clinical trial designed by the non-profit Translational Genomics Research Institute (TGen).

Destroy Pancreatic Cancer was founded by Georgia businessman John Couvillon, who had survived melanoma and brain tumors, before succumbing last year to pancreatic cancer. It was this third and most challenging diagnosis that spurred his advocacy for other patients facing serious disease.

“Stay positive, be grateful and love life,” was a daily mantra for Mr. Couvillon, who promised that he would do everything in his power to destroy pancreatic cancer.

“While he is no longer here with us, it was never lost on John how blessed he was to be able to pay it forward and help provide hope and better options for those battling this disease,” said Atlanta businessman Howard Young, Chair of the Board of Destroy Pancreatic Cancer. Young has survived pancreatic cancer for 15 years, a remarkable feat he attributes to the care he has received from Dr. Daniel D. Von Hoff, TGen Distinguished Professor and Physician-In-Chief.

Dr.

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD